1.疗效标准

1.疗效标准

①近期治愈：自觉症状消失，脾脏缩小至正常，腹水消失，肝功

正常。食道静脉曲张及门静脉口径均有一定改善。②显效：自觉症状

消失，腹水消失，脾脏明显回缩，肝功接近正常，食道静脉及门静脉

口径仅见轻度改善或未见改善。③有效：自觉症状、门脉高压征、肝

功能等各项指标仅有较小改善或其中一、二项有一定改善，其余均

未见改善。④无效：各项指标均未行到改善或加重，其中一、二项指

标曾有过改善旋即复发者，因病情加重并发症未能控制而死亡者。

表1治疗组、对照组体征恢复比较

+:---------+:-------+:-------+:-----------:+:-----------:+:------------:+:------------:+ 体征 | 治疗组（n=154） | 对照组（n=60） | | 治疗前后例数 | | | | 分组 | | +-------------+-------------+--------------+--------------+ | 治疗前 | 治疗后 | 治疗前 | 治疗后 腹 | --- | 例数 | 0 | 93 | 0 | 8 | | | | | | 水 | | | | | | | +--------+-------------+-------------+--------------+--------------+ | | % | △0 | * 60. 38 | 0 | 13. 33 +--------+--------+-------------+-------------+--------------+--------------+ | + | 例数 | 60 | 43 | 30 | 28 | +--------+-------------+-------------+--------------+--------------+ | | % | △38. 96 | * 27. 92 | 50.00 | 46. 67 +--------+--------+-------------+-------------+--------------+--------------+ | + + | 例数 | 94 | 18 | 30 | 24 | +--------+-------------+-------------+--------------+--------------+ | | % | △61. 03 | * 11. 69 | 50. 00 | 40. 00 脾 | ---- | 例数 | 20 | 66 | 0 | 6 | | | | | | 大 | | | | | | | +--------+-------------+-------------+--------------+--------------+ | | % | △12. 98 | * 42. 85 | 0 | 10. 00 +--------+--------+-------------+-------------+--------------+--------------+ | + | 例数 | 49 | 42 | 38 | 34 | +--------+-------------+-------------+--------------+--------------+ | | % | △31.81 | * 27. 27 | 63. 33 | 56.67 +--------+--------+-------------+-------------+--------------+--------------+ | + + | 例数 | 85 | 46 | 22 | 20 | +--------+-------------+-------------+--------------+--------------+ | | % | △55. 19 | * 29.87 | 36. 67 | 33. 23 下肢浮肿 | ------ | 例数 | 2 | 103 | 0 | 10 | +--------+-------------+-------------+--------------+--------------+ | | % | △1.29 | * 66. 88 | 0 | 16. 67 +--------+--------+-------------+-------------+--------------+--------------+ | * | 例数 | 31 | 31 | 24 | 24 | +--------+-------------+-------------+--------------+--------------+ | | % | △20. 12 | * 20. 12 | 40. 00 | 40. 00 +--------+--------+-------------+-------------+--------------+--------------+ | + + | 例数 | 121 | 20 | 36 | 26 | +--------+-------------+-------------+--------------+--------------+ | | % | △78. 57 | * 12. 99 | 60.00 | 43. 33 门 | 12 | | 例数 | 5 | 29 | 10 | 10 | | | | | | 静 | | | | | | | | | | | | 脉 | | | | | | | | | | | | 口 | | | | | | | | | | | | 径 | | | | | | | +--------+-------------+-------------+--------------+--------------+ | | % | △3. 24 | * 18. 83 | 16. 67 | 16.67 +--------+--------+-------------+-------------+--------------+--------------+ | 12 | 例数 | 73 | 87 | 26 | 32

| 〜20 | | | | | | +--------+-------------+-------------+--------------+--------------+ | | % | △47. 40 | * 56. 49 | 43. 33 | 53. 33 +--------+--------+-------------+-------------+--------------+--------------+ | 20 f | 例数 | 76 | 38 | 24 | 18 | +--------+-------------+-------------+--------------+--------------+ | | % | △49. 35 | * 24. 68 | 40. 00 | 30. 00 腹 | --- | 例数 | 5 | 125 | 12 | 12 | | | | | | 水 | | | | | | | +--------+-------------+-------------+--------------+--------------+ | | % | △3. 24 | * 81. 17 | 20.00 | 20. 00 +--------+--------+-------------+-------------+--------------+--------------+ | + | 例数 | 149 | 29 | 48 | 48 | +--------+-------------+-------------+--------------+--------------+ | | % | △96. 75 | * 18. 83 | 80. 00 | 80. 00 注：门静脉口径单位为：mm

△P>0.05 △治疗组、对照组治疗前统计学处理

*P<0.01〜0.05 *治疗组、对照组治疗后统计学处理

表2治疗组、对照组治疗前后检验指标对比

+:---------+:--------+:----:+:----------:+:----------:+:----------:+:----------:+ 体征 | | 治疗组(n=154) | 对照组(n=60) | | | 体征 | | | | | | 治疗前后例数 | | | | | | 分组 | | | +------+------------+------------+------------+------------+ | 例数 | 治疗前 | 治疗后 | 治疗前 | 治疗后 GPT | 25 ↓ | 例数 | 30 | 104 | 6 | 12 | +------+------------+------------+------------+------------+ | | % | △19.48 | * 67. 53 | 10.00 | 20. 00 +---------+------+------------+------------+------------+------------+ | 25 〜50 | 例数 | 23 | 30 | 24 | 24 | +------+------------+------------+------------+------------+ | | % | △14. 94 | * 19. 48 | 40.00 | 40. 00 +---------+------+------------+------------+------------+------------+ | 50↑ | 例数 | 101 | 20 | 30 | 24 | +------+------------+------------+------------+------------+ | | % | △65. 58 | * 12. 99 | 50. 00 | 40. 00 TTT | 6↓ | 例数 | 13 | 96 | 4 | 10 | +------+------------+------------+------------+------------+ | | % | △8.44 | * 62. 34 | 6. 67 | 16.67 +---------+------+------------+------------+------------+------------+ | 6〜12 | 例数 | 79 | 32 | 26 | 24 | +------+------------+------------+------------+------------+ | | % | △51. 30 | * 20. 78 | 43. 33 | 40. 00 +---------+------+------------+------------+------------+------------+ | 12↑ | 例数 | 62 | 26 | 30 | 26 | +------+------------+------------+------------+------------+ | | % | △40. 26 | * 16. 88 | 50.00 | 43.33 A/G | 正常 | 例数 | 7 | 82 | 4 | 8 | +------+------------+------------+------------+------------+ | | % | △4.55 | * 53. 25 | 6. 67 | 13.33 +---------+------+------------+------------+------------+------------+ | G偏高 | 例数 | 55 | 40 | 20 | 22 | +------+------------+------------+------------+------------+ | | % | △35.71 | * 25. 97 | 33. 33 | 36.37 +---------+------+------------+------------+------------+------------+ | 倒置 | 例数 | 92 | 32 | 36 | 30 | +------+------------+------------+------------+------------+ | | % | △59. 74 | * 20. 78 | 60. 00 | 50. 00 γ-球蛋白 | 25↓ | 例数 | 28 | 108 | 10 | 16 | +------+------------+------------+------------+------------+ | | % | △18. 18 | * 70. 13 | 16.67 | 26. 67 +---------+------+------------+------------+------------+------------+ | 25 〜50 | 例数 | 29 | 27 | 14 | 20 | +------+------------+------------+------------+------------+ | | % | △18. 83 | * 17. 53 | 23.33 | 33.33 +---------+------+------------+------------+------------+------------+ | 50 ↑ | 例数 | 93 | 19 | 36 | 24 | +------+------------+------------+------------+------------+ | | % | △62.99 | * 12. 34 | 60. 00 | 40. 00 TBIL | 17 ↓ | 例数 | 98 | 124 | 18 | 24 | +------+------------+------------+------------+------------+ | | % | △63. 64 | * 80. 52 | 30. 00 | 40. 00 +---------+------+------------+------------+------------+------------+ | 17 〜34 | 例数 | 27 | 12 | 20 | 18 | +------+------------+------------+------------+------------+ | | % | △17. 53 | * 7.79 | 33. 33 | 30. 00 +---------+------+------------+------------+------------+------------+

| 34 ↑ | 例数 | 29 | 18 | 22 | 18 | +------+------------+------------+------------+------------+ | | % | △18. 83 | * 11.68 | 36. 67 | 30. 00 HBsAg | --- | 例数 | 52 | 86 | 24 | 44 | +------+------------+------------+------------+------------+ | | % | △33. 77 | * 55.847 | 40. 00 | 73. 33 +---------+------+------------+------------+------------+------------+ | + | 例数 | 102 | 68 | 36 | 16 | +------+------------+------------+------------+------------+ | | % | △66. 23 | * 44. 16 | 60. 00 | 26.67 注：GPT用卡门氏法、TBIL单位：µmol/L △P>0.05 △治疗组、对照组治疗前统计学处理 *P<0.01〜0.05 *治疗组、对照组治疗后统计学处理